{"id":"W2415409512","doi":"10.1016/j.jtho.2016.05.029","title":"Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK –Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls","year":2016,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Astellas Pharma; PharmaMar; AstraZeneca; Novartis Pharmaceuticals Corporation; Pfizer; Eli Lilly and Company","keywords":"Crizotinib; Medicine; Ceritinib; Oncology; Alectinib; ALK inhibitor; Internal medicine; Targeted therapy; Lung cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003671944,0.001386671,0.003835973,0.00101799,0.0002683669,0.001264708,0.0009399985,0.001501655,0.002670393],"category_scores_gemma":[0.006130402,0.0004779824,0.005337873,0.001056255,0.0007537277,0.001154863,0.000603592,0.001638977,0.0002915062],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001326252,"about_ca_system_score_gemma":0.0005422155,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002668802,"about_ca_topic_score_gemma":0.002493023,"domain_scores_codex":[0.9954045,0.002039516,0.0004227074,0.001124533,0.000451083,0.0005577669],"domain_scores_gemma":[0.9964687,0.001618478,0.0008788551,0.0005219742,0.0002276985,0.0002843855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9543521,0.0005395791,0.01926168,0.000427123,0.01214369,0.0001253989,0.00005426223,0.001121624,0.002481939,0.000139357,0.0003870544,0.008966264],"study_design_scores_gemma":[0.1493717,0.1587941,0.6125703,0.000171766,0.05965306,0.0006265215,0.0004525483,0.00774707,0.005060102,0.0009550534,0.004323588,0.0002741242],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904577,0.006759253,0.0004221257,0.0000734713,0.0001985881,0.00009812137,0.001000543,0.00003138733,0.0009588045],"genre_scores_gemma":[0.9979399,0.0005042876,0.0001582699,0.00004915252,0.00008725977,0.00005820686,0.0008097964,0.00001244329,0.0003807692],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003835973,"threshold_uncertainty_score":0.01941931,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03761913424189329,"score_gpt":0.4663444579850001,"score_spread":0.4287253237431068,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}